Jan 29, 2026
What did Dr. Sanjay Gupta say about the efficacy and risks of newly approved Alzheimer’s drugs?
has framed —most prominently —as an important but limited advance: they can modestly slow disease progression by targeting and clearing amyloid plaques, but they are not cures and carry nontrivial ris...